Santhera Pharmaceuticals (Switzerland) Price History

SANN Stock  CHF 14.50  0.04  0.28%   
If you're considering investing in Santhera Stock, it is important to understand the factors that can impact its price. As of today, the current price of Santhera Pharmaceuticals stands at 14.50, as last reported on the 23rd of July, with the highest price reaching 14.72 and the lowest price hitting 14.22 during the day. At this stage we consider Santhera Stock to be somewhat reliable. Santhera Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0193, which indicates the firm had a 0.0193 % return per unit of risk over the last 3 months. We have found thirty technical indicators for Santhera Pharmaceuticals Holding, which you can use to evaluate the volatility of the company. Please validate Santhera Pharmaceuticals' Semi Deviation of 2.14, risk adjusted performance of 0.0382, and Coefficient Of Variation of 2843.37 to confirm if the risk estimate we provide is consistent with the expected return of 0.0467%.
  
Santhera Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0193

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsSANN

Estimated Market Risk

 2.42
  actual daily
21
79% of assets are more volatile

Expected Return

 0.05
  actual daily
1
99% of assets have higher returns

Risk-Adjusted Return

 0.02
  actual daily
1
99% of assets perform better
Based on monthly moving average Santhera Pharmaceuticals is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Santhera Pharmaceuticals by adding it to a well-diversified portfolio.

Santhera Pharmaceuticals Stock Price History Chart

There are several ways to analyze Santhera Stock price data. The simplest method is using a basic Santhera candlestick price chart, which shows Santhera Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceApril 28, 202515.28
Lowest PriceJune 17, 202511.64

Santhera Pharmaceuticals July 23, 2025 Stock Price Synopsis

Various analyses of Santhera Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Santhera Stock. It can be used to describe the percentage change in the price of Santhera Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Santhera Stock.
Santhera Pharmaceuticals Price Rate Of Daily Change 1.00 
Santhera Pharmaceuticals Price Action Indicator 0.05 
Santhera Pharmaceuticals Price Daily Balance Of Power 0.08 

Santhera Pharmaceuticals July 23, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Santhera Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Santhera Pharmaceuticals intraday prices and daily technical indicators to check the level of noise trading in Santhera Stock and then apply it to test your longer-term investment strategies against Santhera.

Santhera Stock Price History Data

The price series of Santhera Pharmaceuticals for the period between Thu, Apr 24, 2025 and Wed, Jul 23, 2025 has a statistical range of 3.64 with a coefficient of variation of 7.54. The price distribution for the period has arithmetic mean of 13.0. The median price for the last 90 days is 12.86. The company completed stock split (10:1) on 2nd of July 2023. Santhera Pharmaceuticals had dividends distributed to its stock-holders on 2022-09-08.
OpenHighLowCloseVolume
07/23/2025
 14.44  14.72  14.22  14.50 
07/22/2025
 14.44  14.72  14.22  14.50  42,096 
07/21/2025
 13.92  14.68  13.74  14.46  53,094 
07/18/2025
 13.28  14.00  13.10  14.00  57,461 
07/17/2025
 12.78  13.30  12.78  13.10  29,066 
07/16/2025
 12.50  12.82  12.48  12.68  14,102 
07/15/2025
 12.02  12.82  12.02  12.58  32,753 
07/14/2025
 12.02  12.46  12.02  12.28  8,079 
07/11/2025
 12.20  12.30  12.02  12.20  19,515 
07/10/2025
 12.20  12.50  12.20  12.22  7,749 
07/09/2025
 12.06  12.30  12.06  12.24  21,274 
07/08/2025
 11.94  12.06  11.80  11.96  15,993 
07/07/2025
 12.12  12.12  11.80  11.90  13,295 
07/04/2025
 12.00  12.18  11.90  12.04  9,869 
07/03/2025
 11.62  12.12  11.62  12.12  15,210 
07/02/2025
 11.94  11.94  11.52  11.72  19,974 
07/01/2025
 11.82  11.96  11.74  11.84  18,743 
06/30/2025
 12.10  12.24  11.80  11.96  36,821 
06/27/2025
 12.06  12.22  11.96  11.98  9,244 
06/26/2025
 11.94  12.24  11.94  12.06  16,081 
06/25/2025
 12.16  12.26  11.90  11.96  33,762 
06/24/2025
 12.56  12.62  11.98  12.12  38,831 
06/23/2025
 11.80  12.62  11.80  12.24  35,134 
06/20/2025
 11.80  12.20  11.80  11.80  31,828 
06/19/2025
 11.74  11.76  11.48  11.74  24,170 
06/18/2025
 11.52  12.00  11.42  11.90  16,508 
06/17/2025
 11.98  12.02  11.58  11.64  48,487 
06/16/2025
 12.66  12.66  12.00  12.04  22,293 
06/13/2025
 12.96  12.96  12.20  12.20  27,247 
06/12/2025
 12.92  13.00  12.70  12.70  21,327 
06/11/2025
 13.10  13.36  12.90  12.94  30,861 
06/10/2025
 13.76  13.86  13.08  13.16  38,609 
06/06/2025
 12.98  13.90  12.98  13.86  28,323 
06/05/2025
 12.82  13.36  12.82  13.14  16,362 
06/04/2025
 13.16  13.30  12.82  13.16  29,547 
06/03/2025
 13.20  13.30  13.02  13.16  11,060 
06/02/2025
 13.26  13.26  12.86  13.16  13,121 
05/30/2025
 12.60  13.26  12.58  13.04  33,813 
05/28/2025
 12.50  12.96  12.40  12.58  23,953 
05/27/2025
 12.48  12.62  12.40  12.48  32,573 
05/26/2025
 12.30  12.72  12.28  12.56  16,201 
05/23/2025
 12.30  12.64  12.10  12.34  31,648 
05/22/2025
 12.64  12.72  12.18  12.28  23,745 
05/21/2025
 13.02  13.06  12.64  12.64  22,763 
05/20/2025
 12.80  13.44  12.78  13.18  34,864 
05/19/2025
 12.90  12.98  12.64  12.72  15,560 
05/16/2025
 13.00  13.06  12.80  12.86  24,428 
05/15/2025
 12.88  13.00  12.80  12.92  27,223 
05/14/2025
 13.24  13.24  12.86  12.86  39,155 
05/13/2025
 13.50  13.94  13.00  13.26  38,560 
05/12/2025
 12.98  13.42  12.66  13.42  34,855 
05/09/2025
 13.30  13.40  12.94  13.18  45,474 
05/08/2025
 13.34  13.60  13.20  13.20  37,483 
05/07/2025
 14.10  14.14  13.34  13.46  55,142 
05/06/2025
 14.46  14.64  14.10  14.22  27,908 
05/05/2025
 14.70  14.96  14.40  14.52  18,661 
05/02/2025
 14.50  14.70  14.08  14.68  42,927 
04/30/2025
 14.80  14.88  14.12  14.50  58,893 
04/29/2025
 14.00  14.90  13.48  14.80  119,151 
04/28/2025
 14.94  15.40  14.70  15.28  48,434 
04/25/2025
 14.48  15.00  14.34  14.84  61,422 

About Santhera Pharmaceuticals Stock history

Santhera Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Santhera is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Santhera Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Santhera Pharmaceuticals stock prices may prove useful in developing a viable investing in Santhera Pharmaceuticals
Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for orphan and other diseases with high unmet medical needs in the European countries. Santhera Pharmaceuticals Holding AG is headquartered in Pratteln, Switzerland. SANTHERA N operates under Biotechnology classification in Switzerland and is traded on Switzerland Exchange. It employs 114 people.

Santhera Pharmaceuticals Stock Technical Analysis

Santhera Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Santhera Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Santhera Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Headlines Timeline Now

   

Headlines Timeline

Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
All  Next Launch Module

Santhera Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Santhera Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Santhera Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Santhera to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Santhera Stock Analysis

When running Santhera Pharmaceuticals' price analysis, check to measure Santhera Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Santhera Pharmaceuticals is operating at the current time. Most of Santhera Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Santhera Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Santhera Pharmaceuticals' price. Additionally, you may evaluate how the addition of Santhera Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.